HomeInsightsPE

Aspira Pathlab & Diagnostics Ltd P/E Ratio

Aspira Pathlab & Diagnostics Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.9 K

stocks traded

Last Updated time: 19 Jul 9.00 AM

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

PE

0

Last updated : 19 Jul 9.00 AM

Key Highlights

    The P/E Ratio of Aspira Pathlab & Diagnostics Ltd is 0 as of 19 Jul 9.00 AM .a1#The P/E Ratio of Aspira Pathlab & Diagnostics Ltd changed from 21.3 on March 2019 to 0 on March 2023 . This represents a CAGR of -100.00% over 3 years. a1#The Latest Trading Price of Aspira Pathlab & Diagnostics Ltd is ₹ 31.37 as of 18 Jul 15:30 .a1#The PE Ratio of Healthcare Industry has changed from 47.8 to 43.6 in 5 years. This represents a CAGR of -1.82%a1# The PE Ratio of Automobile industry is 18.5. The PE Ratio of Finance industry is 24.3. The PE Ratio of Healthcare industry is 58.9. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 20.4. In 2024a1#The Market Cap of Aspira Pathlab & Diagnostics Ltd changed from ₹ 22.41 crore on March 2019 to ₹ 28.67 crore on March 2023 . This represents a CAGR of 5.05% over 5 years. a1#The Revenue of Aspira Pathlab & Diagnostics Ltd changed from ₹ 3.03 crore to ₹ 3.89 crore over 8 quarters. This represents a CAGR of 13.31% a1#The EBITDA of Aspira Pathlab & Diagnostics Ltd changed from ₹ 0.24 crore to ₹ -0.04 crore over 8 quarters. This represents a CAGR of NaN% a1#The Net Pr of Aspira Pathlab & Diagnostics Ltd changed from ₹ -0.29 crore to ₹ -0.5 crore over 8 quarters. This represents a CAGR of 31.31% a1#The Dividend Payout of Aspira Pathlab & Diagnostics Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Aspira Pathlab & Diagnostics Ltd

Period
Mar '190
Mar '200
Mar '2121.3
Mar '2215
Mar '230

Company Fundamentals for Aspira Pathlab & Diagnostics Ltd

Market Cap

32 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

3.2

Day’s High

31.37

Day’s Low

30.65

DTE *

0.3

ROE *

-26.3

52 Week High

49.5

52 Week Low

25.0

ROCE *

-17.8

* All values are consolidated

Last Updated time: 19 Jul 9.00 AM

* All values are consolidated

Last Updated time: 19 Jul 9.00 AM

Image

Aspira Pathlab & Diagnostics Ltd

NSE: ASPIRAPATHLAB

PRICE

31.37

0.00 (0.00%)

stock direction

Last updated : 18 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Aspira Pathlab & Diagnostics Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Aspira Pathlab & Diagnostics Ltd

Market Value

32

Asset Value

6

4.5 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Aspira Pathlab & Diagnostics Ltd032
Apollo Hospitals Enterprise Ltd10493,707
Max Healthcare Institute Ltd8590,718
Fortis Healthcare Ltd6336,880
Global Health Ltd6732,296
Narayana Hrudayalaya Ltd3225,394

Key Valuation Metric of Aspira Pathlab & Diagnostics Ltd

Earnings

-2 Cr

0.0 X

PE Ratio

Market Cap

₹32.29Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-2 Cr

0.0 X

PE Ratio

Market Cap

₹32.29Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Healthcare Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Aspira Pathlab & Diagnostics Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Aspira Pathlab & Diagnostics Ltd

Period
Mar '1922
Mar '2036
Mar '2129
Mar '2267
Mar '2329

* All values are a in crore

×

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Aspira Pathlab & Diagnostics Ltd

Period
Jun '223
Sep '224
Dec '224
Mar '233
Jun '233
Sep '233
Dec '234
Mar '244

* All values are a in crore

×

Historical EBITDA of Aspira Pathlab & Diagnostics Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Aspira Pathlab & Diagnostics Ltd

Period
Jun '220
Sep '221
Dec '221
Mar '230
Jun '230
Sep '230
Dec '230
Mar '240

* All values are a in crore

×

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Aspira Pathlab & Diagnostics Ltd

Period
Jun '220
Sep '220
Dec '220
Mar '230
Jun '23-1
Sep '23-1
Dec '23-1
Mar '240

* All values are a in crore

×

Historical Dividend Payout of Aspira Pathlab & Diagnostics Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Aspira Pathlab & Diagnostics Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Aspira Pathlab & Diagnostics Ltd

About Aspira Pathlab & Diagnostics Ltd

    Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd, 1973. The Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs. 7/- per share) on preferential basis to promoters & group of strategic investors not forming part of the promoter. The allotment was made on 19th November 2016 & listing & trading approval is awaited. The paid-up capital as on 31st March 2017 was 5193000 equity shares of Rs. 10/- each. The Company has changed its object clause on 10th August 2016; its present name was changed on 16th November 2016 & registered office of the company was shifted from State of West Bengal to State of Maharashtra, vide order dated 18th November, 2016 & company again shifted its registered office within the city limit of Mumbai on 17th March, 2017. During the year 2017, the Company applied to BSE Limited on 27th July 2017 under Direct Listing norms of BSE Limited for listing & trading of its securities at BSE Limited. During the year 2018-19, issued, subscribed and paid- up capital of the of the Company has increased from 5,19,30,000 to Rs. 13,69,30,000/- divided into 81,93,000 Equity Shares of Rs. 10/- each and 55,00,000 9% Non-Cumulative, Non-convertible, Non-Participating Redeemable Preference Shares of Rs. 10/- each. The Company got delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited w.e.f. April 12th, 2018 and October 15th , 2018 respectively.

Aspira Pathlab & Diagnostics Ltd News Hub

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

21 May 202412:07

News

Aspira Pathlab & Diagnostics revises board meeting date

Aspira Pathlab & Diagnostics has revised the meeting of the Board of Directors which was s...

Read more

06 Feb 202412:39

News

Aspira Pathlab & Diagnostics to conduct board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

02 Feb 202415:34

News

Aspira Pathlab & Diagnostics to hold board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

30 Oct 202316:10

News

Aspira Pathlab & Diagnostics schedules AGM

Aspira Pathlab & Diagnostics announced that the Annual General Meeting (AGM) of the compan...

Read more

18 Aug 202314:39

News

Aspira Pathlab & Diagnostics to hold board meeting

Aspira Pathlab & Diagnostics will hold a meeting of the Board of Directors of the Company ...

Read more

26 Jul 202317:18

Product Composition by Percentage (Revenue)

FAQs for PE of Aspira Pathlab & Diagnostics Ltd

What is Aspira Pathlab & Diagnostics Ltd current share price?

The current market price of Aspira Pathlab & Diagnostics Ltd as of July 19, 2024 is ₹31.37.

What is Aspira Pathlab & Diagnostics Ltd's market cap?

Aspira Pathlab & Diagnostics Ltd's market capitalisation stood at ₹32 Cr as of July 19, 2024

What are Aspira Pathlab & Diagnostics Ltd's total net assets?

According to Aspira Pathlab & Diagnostics Ltd's most recent financial filings, the company's net assets total ₹5.9 Cr.

Is Aspira Pathlab & Diagnostics Ltd making a profit or loss?

Aspira Pathlab & Diagnostics Ltd's net Profit as of July 19, 2024 is close to ₹-2 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199